Chorea induced by low-dose trazodone.
نویسنده
چکیده
cause movement disorders. CT brain and chest radiograph were normal. It was decided not to perform MRI brain as it was felt that the probability of an ischaemic lesion not visualised by CT was very low. Routine bloods demonstrated no abnormalities in the full blood count, liver function or renal function. The patient had been noted to be hyponatraemic for at least 2 years (around 125–130 mmol/l), but her plasma osmolarity was normal and there had been no recent changes in her plasma sodium levels. ESR was 8 mm/h. Thyroid function, blood glucose, calcium, magnesium, phosphate, serum caeruloplasmin, vitamin D and parathyroid hormone levels were all normal. The anti-streptolysin O titre was normal ( ! 200 U/ml). Anti-nuclear antibody (titre 1: 160) and anti-cardiolipin antibodies were positive, but the patient did not meet the American College of Rheumatology criteria for SLE or anti-phospholipid antibody syndrome and was anti-dsDNA negative with normal serum complement. Anti-basal ganglia antibodies were negative. Given the late age of onset and lack of family history it was decided not to perform genetic testing for Huntington’s disease. CA-125 was elevated but pelvic ultrasound and CT abdomen demonstrated no ovarian or other malignancy. The patient was discharged 12 days after admission with no further occurrence of chorea.
منابع مشابه
Trazodone in the elderly: risk of extrapyramidal acute events.
Trazodone is a second-generation atypical antidepressant exercising selective inhibitory action on the transport of serotonin. It also has an antagonist effect, similar to nefazodone, on the 5HT1 and 5HT2 receptors, probably due to the therapeutic effects of such substances. It is very effective in the treatment of depression, in anxiety and insomnia. Its known side effects mainly occur with pr...
متن کاملErratum to: Rediscovering Trazodone for the Treatment of Major Depressive Disorder
Trazodone is a triazolopyridine derivative that belongs to the class of serotonin receptor antagonists and reuptake inhibitors (SARIs). The drug is approved and marketed in several countries worldwide for the treatment of major depressive disorder (MDD) in adult patients. In clinical studies, trazodone has demonstrated comparable antidepressant activity to other drug classes, including tricycli...
متن کاملUse of trazodone as an adjunctive agent in the treatment of canine anxiety disorders: 56 cases (1995-2007).
OBJECTIVE To evaluate efficacy of trazodone hydrochloride as an adjunctive treatment for anxiety disorders as well as treatment protocol, dose range, concurrent drug use, adverse events, and therapeutic response in dogs unresponsive to other pharmacologic agents. DESIGN Retrospective case series. ANIMALS 56 dogs with anxiety disorders treated at a referral veterinary behavior clinic. PROC...
متن کاملTrazodone increases arousal threshold in obstructive sleep apnoea.
A low arousal threshold is believed to predispose to breathing instability during sleep. The present authors hypothesised that trazodone, a nonmyorelaxant sleep-promoting agent, would increase the effort-related arousal threshold in obstructive sleep apnoea (OSA) patients. In total, nine OSA patients, mean+/-sd age 49+/-9 yrs, apnoea/hypopnoea index 52+/-32 events.h(-1), were studied on 2 night...
متن کاملTrazodone Increases Arousal Threshold in Obstructive Sleep Apnea
A low arousal threshold is believed to predispose to breathing instability during sleep. We hypothesized that trazodone, a non-myorelaxant sleep promoting agent, would increase the effort-related arousal threshold in obstructive sleep apnea (OSA) patients. Nine OSA patients (age 49±9 yr AHI 52±32 events/h) were studied on two nights, one with trazodone 100mg and one with a placebo, in a double ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European neurology
دوره 55 2 شماره
صفحات -
تاریخ انتشار 2006